| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b3132aee00ba2de00e691d3ead66b4ff |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B01J20-205
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0053
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B01J20-28061
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B01J20-28064
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B01J20-28066
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B01J20-28023 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/B01J20-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/B01J20-20 |
| filingDate |
2015-04-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ba49f26754c58cee9464ada2e0a18c2f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_501254cdbc68800241dfef05826dbd13
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d5712c6f2eced2926e2679c9361a378d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_08d932a14a1162c74d6c8cbf5f964005 |
| publicationDate |
2016-10-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2016296558-A1 |
| titleOfInvention |
Adsorbent for reducing uremic toxins in vivo |
| abstract |
An adsorbent for reducing uremic toxins in vivo includes polyacrylonitrile-based activated carbon fibers having the following properties: a) an average diameter of 5 μm to 30 μm; b) a BET specific surface area of more than 390 m 2 /g; c) a total acidic group content of larger than 1.2 meq/g or a total basic group content of larger than 1 meq/g. Because the adsorbent of the present disclosure has a higher adsorption capacity for precursors of uremic toxins than for the normal enzyme protein in intestinal tract, the adsorbent of the present disclosure can effectively prevent the deterioration of renal function, and thus can be used as a therapeutic agent and a preventive for kidney disease. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11413185-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2023154869-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111050584-A |
| priorityDate |
2015-04-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |